Most healthcare providers recommend either discontinuing GLP-1 therapy or switching to breastfeeding-compatible alternatives until lactation ends, due to limited pharmacokinetic and neonatal safety data for these medications in human milk
It is a Refreshed look that respects her original anatomy while optimizing her metabolic health
Zhang, X., Wu, F
& Curno, M
plans to test Medicare, Medicaid coverage for weight-loss drugs, Washington Post reports, Reuters (2025) Medicare coverage of GLP-1 drugs, Library of Congress (2024) WEGOVY- semaglutide injection, solution, DailyMed (2024) Supriya Rao, MD, gastroenterologist, director of medical weight loss at Lowell General Hospital, and clinical assistant professor at Tufts University School of Medicine Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Also, the LIVE trial reported higher resting heart rate and more serious cardiac events with liraglutide versus placebo [45], supporting a cautious approach in this phenotype
